Differentiate products and establish key partnerships.
Unrelenting increases in healthcare costs and disappointing patient outcomes are accelerating the interest in value-based contracts (VBCs). By putting data and patients at the center of the transformation, VBCs create a foundation for change, an opportunity for real differentiation, and can unlock new win-win partnership opportunities
identify the right opportunities, foster collaboration, and operationalize contracts.
ClosedLoop generates explainable predictions using thousands of auto-generated, clinically relevant contributing factors.
Determine
Determine which pharmaceuticals work best with value-based pricing agreements and identify opportunities for bundled offerings or digital therapeutics that drive outcomes
Assess
Assess specific opportunities with HCO partners using their data and reach consensus on specific cohorts, key outcomes, and standards for specific metrics
Choose
Choose the right treatments and identify the specific patient cohorts and outcomes that align stakeholders
Adverse Glycemic Events & Continuous Glucose Monitoring
Improve glycemic control and avoid adverse outcomes.